foxo4-dri senolytic 2023 2024

foxo4-dri senolytic 2023 2024 Peptide Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Cellular Senescence as a Targetable

Name: foxo4-dri senolytic 2023 2024 Peptide Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Cellular Senescence as a Targetable
Brand: www.marsberger-treibhaus.de
SKU: 59435867372
Price: 26.80 USD
Availability: InStock
Rating: 4.635400000000001 (6 reviews)

Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series JACC: Basic to Translational Science The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect

SKU: 59435867372 · From www.marsberger-treibhaus.de

4.6

USD26.80 USD75.80

Pay in 4 interest-free payments of $6.70 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model